WGBS News Alert Wafergen Bio-Systems (WGBS) 4.50 09/28/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wafergen Bio-Systems (WGBS) 4.50 $WGBS

WaferGen Bio-systems to Present at Upcoming Investment Conferences
PR Newswire - Wed Sep 03, 2:45PM CDT
WaferGen Bio-systems, Inc. (Nasdaq: WGBS) today announced that Ivan Trifunovich, President and Chief Executive Officer, will present at the following investment conferences:

WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million
PR Newswire - Wed Aug 27, 2:15PM CDT
WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced that it has completed its previously announced underwritten public offering of units of common stock and warrants at a price of $10,000 per unit for gross proceeds of $20 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The shares and warrants are immediately separable and will be issued separately.

WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ
PR Newswire - Fri Aug 22, 7:00AM CDT
WaferGen Bio-systems, Inc. (NASDAQ: WGBS) today announced the pricing of an underwritten public offering of units of common stock and warrants at a price of $10,000 per unit for gross proceeds of $20 million, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. The shares and warrants are immediately separable and will be issued separately. The shares of common stock are expected to begin trading on The NASDAQ Stock Market under the ticker symbol "WGBS" on Friday, August 22, 2014. The offering is expected to close on August 27, 2014, subject to the satisfaction or waiver of customary closing conditions.

WaferGen Announces Appointment of Chief Operating Officer and Chief Financial Officer
PR Newswire - Mon Aug 18, 8:01AM CDT
WaferGen Bio-systems, Inc. (OTCQB: WGBS) today announced that the Company has appointed two seasoned executives to its senior management team, Keith Warner as Chief Operating Officer and Michael Henighan as Chief Financial Officer.

WaferGen Bio-systems Reports Strong Revenue Growth for Q2 2014
PR Newswire - Thu Aug 07, 3:01PM CDT
WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today its financial results for the second quarter ended June 30, 2014.

WaferGen Bio-systems Announces Second Quarter 2014 Conference Call
PR Newswire - Mon Aug 04, 3:01PM CDT
WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today that it will host a conference call to discuss its financial results for the quarter ended June 30, 2014. The call will be held on Thursday, August 7, 2014 at 5:00 pm ET and will be hosted by Ivan Trifunovich, President and CEO of WaferGen Bio-systems.

WaferGen Bio-systems Announces a Commercial Partnership with a Major Molecular Diagnostic Laboratory
PR Newswire - Thu Jul 31, 8:01AM CDT
WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today a commercial partnership with Molecular Pathology Laboratory Network, Inc. (MPLN) with the goal of developing Next-Generation sequencing (NGS) based clinical tests.

WaferGen Bio-Systems Announces Appointment of Ivan Trifunovich as Chairman of the Board; Joel Kanter to Serve as Lead Independent Director
PR Newswire - Fri Jul 18, 8:01AM CDT
WaferGen Bio-systems, Inc. (OTCBB: WGBSD) today announced that its Board of Directors has appointed Ivan Trifunovich, the company's President and Chief Executive Officer, as Chairman of the Board. Joel Kanter, a director of the company since 2007, will serve as lead independent director. Alnoor Shivji, the company's Chairman since 2002, resigned from the board to focus full time on a new startup venture.

WaferGen Bio-systems Announces Reverse Stock Split as it Pursues NASDAQ Listing
PR Newswire - Mon Jun 30, 3:02PM CDT
WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today a 1-for-10 reverse stock split of its outstanding common stock. The company completed the reverse stock split as it seeks to list its common stock on the NASDAQ Capital Market.

WaferGen Bio-systems Announces Fourth Quarter and Year-End 2013 Conference Call
PR Newswire - Tue Mar 18, 5:12PM CDT
WaferGen Bio-systems, Inc. (WGBS) announced today that it will host a conference call and live audio webcast to discuss its financial results for the quarter and year ended December 31, 2013. The call and webcast will be held on Monday, March 24, 2014 at 11:00 am ET and will be hosted by Ivan Trifunovich, President and CEO of WaferGen Bio-systems.

WaferGen Bio-systems Reports Solid Revenue Growth for Q4 and the Year 2013
PR Newswire - Thu Mar 13, 4:42PM CDT
WaferGen Bio-systems, Inc. (OTCQB: WGBS) announced today its financial results for the fourth quarter and year ended December 31, 2013.

Hepatitis C treatment guidelines Markets to 2019 - Market Shares, Strategies, and Forecasts Report Available Online By ResearchMoz.us
PR Newswire - Wed Feb 19, 5:31AM CST
ResearchMoz.us includes new market research report "Hepatitis C Therapeutics in Major Developed Markets to 2019" to its huge collection of research reports.

Anvil Rock Ventures LLC Introduces FirstFrontiersMan.com
PR Newswire - Tue Jan 28, 8:24AM CST
Arizona-based internet company, Anvil Rock Ventures LLC, today announced that its new online store is open for business at www.FirstFrontiersMan.com.

WaferGen Bio-systems Announces New Funding from Private Placement
PR Newswire - Tue Aug 27, 7:40PM CDT
WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today that it has commenced a private placement to accredited investors of up to $17.25 million of units consisting of shares of common stock, shares of Series 1 convertible preferred stock and warrants to purchase shares of common stock.

WaferGen Bio-systems Announces Reverse Stock Split and Capital Restructuring
PR Newswire - Tue Aug 27, 7:38PM CDT
WaferGen Bio-systems, Inc. (OTCBB: WGBS) announced today a 1-for-99.39 reverse stock split of its outstanding common stock and the completion of a capital restructuring of its Series A-1 Convertible Preferred Stock, convertible promissory notes and warrants issued in May 2011. The Company completed the reverse stock split and capital restructuring as part of its efforts to improve its capital structure and raise additional capital.

WaferGen Launches SmartChip TE - A Novel Target Enrichment Solution for Next-Gen Sequencing (NGS) Aimed at Clinical Applications
PR Newswire - Thu May 09, 10:04AM CDT
WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the launch of its new SmartChip TE product - a PCR-based target enrichment solution for sample preparation prior to targeted re-sequencing on Next-Gen platforms. As clinical Next-Gen sequencing rapidly expands into the mainstream molecular testing market, the growth of this market segment is expected to be explosive. Some analysts project that the market for targeted clinical sequencing alone will reach $750M by 2015. SmartChip TE addresses CLIA-certified and clinical research laboratories' significant unmet needs in sequencing-based testing by providing superior flexibility, specificity, and sensitivity. The superior performance of this new product is based on WaferGen's proprietary technology that relies on massively parallel singleplex PCR reactions, where amplification is cleaner and better controlled, thereby providing more accurate results in the downstream sequencing step. Each target is amplified in an individual reaction, yielding close to eq

WaferGen Partners with Salk Institute to Establish a Nano-qPCR Core Lab
PR Newswire - Mon Mar 11, 8:10AM CDT
The Salk Institute and WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the formation of a nano-qPCR Core Laboratory under the guidance of Ronald M. Evans, Professor and March of Dimes Chair in Molecular and Developmental Biology at Salk. The lab will utilize WaferGen's SmartChip System as the backbone technology for high-throughput real-time PCR studies. A major focus will be on designing and testing libraries of assays targeting receptors and transcriptional regulators for important functional pathways, thereby interrogating entire regulatory networks in a highly parallel fashion. It is also envisioned that the nano-qPCR Core Lab will be an important resource for the larger Salk community.

WaferGen Bio-systems Announces Highly Successful Initial Customer Testing of Its Previously Unannounced Novel Target Enrichment Technology for Next-Gen Sequencing (NGS)
PR Newswire - Tue Jan 08, 8:00AM CST
WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the successful completion of a proof-of-concept study using its newly-developed proprietary nano-qPCR technology for sample preparation prior to targeted re-sequencing on Next-Gen platforms. The results can be viewed in white paper form at:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 23

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 290

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading
Thunes Boosts Bhutan Remittances with Instant Payments

Updated Category News Views 136

Thunes' Network Expands to Bhutan: A Game Changer I'll say one thing clear—Thunes isn't messing around. They've just opened the gates for real-time payouts to Bhutan, and it's going to be a game-changer for those living abroad who want to send money back home. Look, for years, Non-Resident Bhutanese have been diving into hoops just to get their bucks across borders....

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 258

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 157

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 530

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 416

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 124

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 424

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
LONGi's Four Paths to Global Green Development

Updated Category News Views 19

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading

Top 5 Most Recently Viewed Articles

Trade Developments Impacting Global Stocks and Currencies

Updated Category News Views 225

Trade Developments Impacting Global Stocks During the latest trading session in Asia, futures for the S&P 500 and Nasdaq 100 showed positive momentum, increasing by 0.5% and 0.6% respectively. This positive trend comes after Friday's historic closing levels. The surge in optimism can be largely attributed to developments surrounding a trade agreement between the US and...

Continue Reading
Subaru Launches Gear for Good Initiative for Youth Soccer Growth

Updated Category News Views 152

Subaru Champions Youth Soccer with Gear for Good Initiative Subaru of America is proud to announce its engaging initiative, Gear for Good, aimed at nurturing the budding talent in youth soccer. This project represents Subaru's unwavering commitment to community involvement, ensuring that every child has access to the necessary tools to pursue their passion for soccer....

Continue Reading
Discover Nykredit's Upcoming Mortgage Bond Auction Insights

Updated Category News Views 306

Nykredit's Mortgage Bond Auction Overview Nykredit Realkredit A/S, a prominent financial institution, is organizing an exciting auction designed for interested investors. This event aims to enhance participation in the mortgage bond market, making it a notable opportunity for those seeking investment options. What to Expect at the Auction Scheduled for a future date, the...

Continue Reading
Paperclip Partners with Apis Productions for Robust Data Security

Updated Category News Views 106

Paperclip Collaborates with Apis Productions for Enhanced Security In an exciting new development, Paperclip, Inc. (OTCMKTS: PCPJ) has announced its partnership with Apis Productions to launch cutting-edge data security solutions. This collaboration focuses on integrating Paperclip’s innovative SAFE encryption technology within Apis Productions’ insurance technology...

Continue Reading
Medical Imaging Equipment Services Market Set for Growth Surge

Updated Category News Views 91

Overview of the Medical Imaging Equipment Services Market The Medical Imaging Equipment Services Market is set for a period of substantial growth, with projections indicating an increase from USD 60 billion in 2024 to USD 85 billion by 2031. This growth trajectory correlates with a compound annual growth rate (CAGR) of 5.0%. Several factors are contributing to this steady...

Continue Reading